Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Biogen (NASDAQ:BIIB) Given “Outperform” Rating at Oppenheimer | news.google.com • |
Biogen Inc. (NASDAQ:BIIB) Short Interest Down 8.2% in April | news.google.com • |
The Analyst Landscape: 27 Takes On Biogen- Benzinga | news.google.com • |
7 Retirement Stocks to Buy at a 52-Week Low in April | investorplace.com • |
Biogen's Revenue Dip Meets Cost Cuts In Q1 (Rating Upgrade) (NASDAQ:BIIB) | news.google.com • |
Cwm LLC Decreases Stake in Biogen Inc. (NASDAQ:BIIB) | news.google.com • |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-24 | 2024-03 | 3.45 | 3.67 | 0.22 | 6.38% |
2024-02-13 | 2023-12 | 3.16 | 2.95 | -0.21 | -6.65% |
2023-11-08 | 2023-09 | 3.99 | 4.36 | 0.37 | 9.27% |
2023-07-25 | 2023-06 | 3.77 | 4.02 | 0.25 | 6.63% |
2023-04-25 | 2023-03 | 3.25 | 3.4 | 0.15 | 4.62% |
2023-02-15 | 2022-12 | 3.51 | 4.05 | 0.54 | 15.38% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-10 | Morgan Stanley | Upgrade | Overweight | Overweight |
2023-09-05 | HSBC | Upgrade | Buy | |
2023-09-04 | Morgan Stanley | Upgrade | Overweight | Overweight |
2023-08-28 | RBC Capital | Upgrade | Outperform | Outperform |
2023-08-13 | Mizuho | Upgrade | Buy | Buy |
2023-08-07 | Atlantic Equities | Upgrade | Neutral | Neutral |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-02-15 | ALEXANDER SUSAN H | Officer | 51.68K | Conversion of Exercise of derivative security |
2023-06-25 | DORSA CAROLINE D | Director | 24.82K | Stock Award(Grant) |
2024-02-15 | GREGORY GINGER | Officer | 13.58K | Conversion of Exercise of derivative security |
2023-06-25 | HAWKINS WILLIAM A III | Director | 5.15K | Stock Award(Grant) |
2024-02-15 | IZZAR RACHID | Officer | 9.70K | Conversion of Exercise of derivative security |
2024-02-15 | KRAMER ROBIN C | Officer | 6.23K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Primecap Management Company | 16.03M | 4.56B | 11.07% |
2023-06-29 | Blackrock Inc. | 14.07M | 4.01B | 9.71% |
2023-06-29 | Vanguard Group Inc | 12.20M | 3.47B | 8.42% |
2023-06-29 | State Street Corporation | 6.89M | 1.96B | 4.75% |
2023-06-29 | Wellington Management Group, LLP | 5.35M | 1.52B | 3.69% |
2023-06-29 | JP Morgan Chase & Company | 4.47M | 1.27B | 3.09% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard/Primecap Fund | 9.00M | 2.56B | 6.21% |
2023-07-30 | Vanguard Specialized-Health Care Fund | 4.56M | 1.23B | 3.15% |
2023-06-29 | Vanguard Total Stock Market Index Fund | 4.51M | 1.28B | 3.11% |
2023-06-29 | Vanguard 500 Index Fund | 3.45M | 981.68M | 2.38% |
2023-08-30 | Invesco ETF Tr-Invesco QQQ Tr, Series 1 ETF | 2.45M | 655.85M | 1.69% |
2023-06-29 | Vanguard Horizon Fund-Capital Opportunity Fund | 2.18M | 621.04M | 1.51% |
Split | Date |
---|---|
3 : 1 | 2001-01-18 |
2 : 1 | 1999-12-21 |
-
About Destiny Tech100
Destiny's flagship offering, the Destiny Tech100, will be a publicly-listed portfolio of 100 of the top venture-backed private technology companies, providing everyday investors access to many of the world's most exciting private businesses.
Current Tech100 holdings include: SpaceX, OpenAI, Epic Games, Discord, Superhuman, and Stripe. For a comprehensive list of holdings, visit the fund website www.destiny.xyz/tech100.
Image for Press Release 1867753
View source version on businesswire.com: https://www.businesswire.com/news/home/20240327776952/en/
-
About Destiny Tech100
Destiny's flagship offering, the Destiny Tech100, will be a publicly-listed portfolio of 100 of the top venture-backed private technology companies, providing everyday investors access to many of the world's most exciting private businesses.
Current Tech100 holdings include: SpaceX, OpenAI, Epic Games, Discord, Superhuman, and Stripe. For a comprehensive list of holdings, visit the fund website www.destiny.xyz/tech100.
Image for Press Release 1867753
View source version on businesswire.com: https://www.businesswire.com/news/home/20240327776952/en/
-
5-6 more points down and I’m in
-
-
-
-
Let me introduce you to a platform I discovered where you can sell your Bitcoin and other top Cryptocurrencies at the exact rate any where in the world. Reach out to 𝐅𝐑𝐀𝐍𝐊𝐉𝐀𝐒𝐎𝐍𝐅𝐗_𝐎𝐅𝐅𝐈𝐂𝐈𝐀𝐋_𝐓𝐑𝐀𝐃𝐄𝐑 on 𝐈𝐍𝐒𝐓𝐀𝐆𝐑𝐀𝐌 It is safe, secure & reliable. The interesting part of it is that, you don’t have to drop your vital informations before you sell to them. You sell and get your money directly sent to your bank account immediately your deposit is confirmed.
-
I can proudly say my broker is one of the best manager Karen J Adams in Crypto market, I invested $500 and I made $5,810 after 7days of trade. Message her to be your guidance about trading she is on What'sApp +𝟏𝟖𝟏𝟐𝟐𝟕𝟎𝟔𝟖𝟎𝟕
-
All thanks to Mrs. Karen J Adams that helped me achieve my dreams through her trading program, I made over $30,000 in duration of 4 days she's so excellent and amazing. Visit her on TELEGRAM ᏦᎪᎡᎬΝ Ꭻ ᎪᎠᎪᎷՏ or WhatsApp +❶❽❶❷❷❼⓿❻❽⓿❼
-
NFA Guys!!!! LOOK into ATER !!! Look at the facts, Numbers are lined up & we own float SI is above 40% , 100% utilization for 72 days, we own the float, CTB is high, we just need volume, SQUEEZE bound to happen Join ATER discord n let us know ur new.HODL!! SQUEEZE PLAY!!! Just need volume!! Lookup AnonFtheHF vids on youtube or
DO YOUR OWN DD IF YOU DONT BELIVE, SEE FOR YOURSELF!!!!
Just a BULL sticking it to SHORTS/HF. Love ya’ll!!!Peace out brothers!! Ticker: ATER
NFA -
-
-
-
-
$CRBU
Take a look at Caribou Biosciences. $CRBULeader in CRISPR Gene editing. Cure to all diseases.
Founded by Nobel winner Jennifer Doudna and CEO Rachel Haurwitz.
Market cap 1.5 Billion.
They have 14,453,932 shares of Intellia (NTLA). Worth $2.5 Billion alone. Check out filings:
https://www.sec.gov/edgar/browse/?CIK=1619856&owner=exclude
They have about $500 Million in cash from recent IPO.
Listen to The Code Breaker by Walter Isaacson on Audible. https://www.audible.com/pd?asin=179711705X&source_code=ASSORAP0511160006
Check out patents:
Working on cure for cancer.
This has potential for x 1000
New CRISPR/Cas9 patent issued to Carribou Bio recently
Do your own due diligence.
Good luck
-
-
Biogen (NASDAQ:BIIB) Given “Outperform” Rating at Oppenheimer
news.google.com • -
Biogen Inc. (NASDAQ:BIIB) Short Interest Down 8.2% in April
news.google.com • -
The Analyst Landscape: 27 Takes On Biogen- Benzinga
news.google.com • -
7 Retirement Stocks to Buy at a 52-Week Low in April
investorplace.com • -
Cwm LLC Decreases Stake in Biogen Inc. (NASDAQ:BIIB)
news.google.com • -
FY2024 EPS Estimates for Biogen Inc. (NASDAQ:BIIB) Boosted by Analyst
news.google.com • -
Q3 2024 EPS Estimates for Biogen Inc. Lifted by Analyst (NASDAQ:BIIB)
news.google.com • -
How to Take Advantage of moves in (BIIB)
news.google.com • -
Barclays Lowers Biogen (NASDAQ:BIIB) Price Target to $200.00
news.google.com • -
Q2 2024 EPS Estimates for Biogen Inc. Lifted by Analyst (NASDAQ:BIIB)
news.google.com • -
BIIB June 7th Options Begin Trading
news.google.com • -
Biogen (NASDAQ:BIIB) Rating Reiterated by Needham & Company LLC
news.google.com • -
Biogen First Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
news.google.com • -
Why Biogen Stock Leaped Nearly 5% Higher Today
news.google.com • -
Why Biogen Stock Leaped Nearly 5% Higher Today
news.google.com • -
3-Stock Lunch: TXN, BIIB & CMG
youtube.com • -
Biogen (BIIB) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
news.google.com • -
Biogen (BIIB) Q1 Earnings Beat, Stock Up on Alzheimer Drug Uptake
news.google.com • -
Biogen (BIIB) Q1 2024 Earnings Call Transcript
news.google.com • -
BIIB Stock Earnings: Biogen Beats EPS, Misses Revenue for Q1 2024
news.google.com • -
BIIB Stock: Biogen Tops Q1 Estimates with Alzheimer's Boost
news.google.com • -
Biogen (BIIB) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
news.google.com • -
Biogen stock gains on Q1 earnings beat (NASDAQ:BIIB)
news.google.com • -
Biogen tops earnings expectations but revenue falls short
news.google.com • -
Cerity Partners LLC Increases Position in Biogen Inc. (NASDAQ:BIIB)
news.google.com • -
Should You Be Confident in Biogen (BIIB)?
news.google.com • -
Biogen Inc. (BIIB) Stifel 2024 Virtual CNS Days (Transcript)
seekingalpha.com • -
Three-Stock Lunch: Biogen, DocuSign & Gap
youtube.com • -
Biotechs on the Rise: 3 Stocks to Buy for a Shot of Profits
investorplace.com • -
EU medicines regulator backs Biogen's ALS drug
reuters.com • -
From Zero to Hero: 7 Stock Losers That Could Turn Things Around in 2024
investorplace.com • -
Where Are Biotech ETFs Headed After Q4 Earnings?
zacks.com • -
Biogen's rare genetic disorder drug gets approval in EU
reuters.com • -
Wall Street Brunch: Retail Inflation In Focus
seekingalpha.com • -
7 Biotech Stocks Fighting America's Deadliest Diseases
investorplace.com • -
Biogen Ends Development of Alzheimer's Drug Aduhelm
barrons.com • -
Biogen halts development of controversial Alzheimer's drug
marketwatch.com • -
Time to Load Up on This New Magnificent 7 of ‘Strong Buy' Stocks
investorplace.com • -
2 low-priced gene therapy stocks to speculate on
marketbeat.com • -
Healthcare Heroes: 3 Stocks Innovating in Medicine and Wellness
investorplace.com • -
Top 3 Healthcare Stock Picks for the New Year
investorplace.com • -
Wells Fargo's top pharma picks for 2024
youtube.com • -
Mind-Bending Growth: 3 Psychedelic Stocks With Trippy Potential
investorplace.com • -
Alzheimer's Disease Drug Development: Another Lost Year
seekingalpha.com •